BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 597823)

  • 1. High incidence of cardiomyopathy in children treated with adriamycin and DTIC in combination chemotherapy.
    Smith PJ; Ekert H; Waters Kd; Matthews RN
    Cancer Treat Rep; 1977 Dec; 61(9):1736-8. PubMed ID: 597823
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiomyopathy in adults after combination adriamycin and DTIC.
    Beretta G; Villani F
    Cancer Treat Rep; 1980; 64(2-3):353. PubMed ID: 7407770
    [No Abstract]   [Full Text] [Related]  

  • 3. A possible neurologic complication of DTIC.
    Paterson AH; McPherson TA
    Cancer Treat Rep; 1977; 61(1):105-6. PubMed ID: 861957
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of combination adriamycin (NSC-123127) and DTIC (NSC-45388) in children with advanced stage IV neuroblastoma.
    Leikin S; Bernstein I; Evans A; Finklestein J; Hittle R; Klemperer M
    Cancer Chemother Rep; 1975; 59(5):1015-8. PubMed ID: 1106842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Description of a case of acute neurological toxicity after DTIC-adriamycin-vincristine therapy (author's transl)].
    Rosso R; Brema F; Porcile G
    Tumori; 1975; 61(3):313-4. PubMed ID: 1162754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy of non-resectable soft tissue sarcomas.
    Kessinger A; Foley JF; Lemon HM
    Nebr Med J; 1975 May; 60(5):147-153. PubMed ID: 1128734
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors.
    Cangir A; Morgan SK; Land VJ; Pullen J; Starling SA; Nitschke R
    Med Pediatr Oncol; 1976; 2(2):183-90. PubMed ID: 958160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dimethyl-triazeno-imidazole-carboxamide (DTIC) in combination chemotherapy for childhood neuroblastoma (author's transl)].
    Mutz ID; Urban CE
    Wien Klin Wochenschr; 1978 Dec; 90(24):867-70. PubMed ID: 741754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of DTIC (NSC-45388) in the chemotherapy of sarcomas.
    Gottlieb JA; Benjamin RS; Baker LH; O'Bryan RM; Sinkovics JG; Hoogstraten B; Quagliana JM; Rivkin SE; Bodey GP; Rodriguez V; Blumenschein GR; Saiki JH; Coltman C; Burgess MA; Sullivan P; Thigpen T; Bottomley R; Balcerzak S; Moon TE
    Cancer Treat Rep; 1976 Feb; 60(2):199-203. PubMed ID: 769974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease.
    Beretta G; Bonadonna G; Bajetta E; Tancini G; De Lena M; Azzarelli A; Veronesi U
    Cancer Treat Rep; 1976 Feb; 60(2):205-11. PubMed ID: 769975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of uterine leiomyosarcomas treated with vincristine, Adriamycin, and dimethyl-triazeno-imidazole carboximide.
    Azizi F; Bitran J; Javehari G; Herbst AL
    Am J Obstet Gynecol; 1979 Feb; 133(4):379-81. PubMed ID: 433999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Echocardiographic evaluation of adriamycin cardiotoxicity during polychemotherapy (author's transl)].
    Christmann D; Bareiss P; Boilletot A; Bergerat JP; Oberling F
    Nouv Rev Fr Hematol (1978); 1981; 23(3):149-54. PubMed ID: 7290990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J; Oliveira Costa F; Pimentel P
    Cancer Treat Rep; 1976 Sep; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract]   [Full Text] [Related]  

  • 14. [A reserve chemotherapy for Hodgkin's disease (author's transl)].
    Amiel JL; Ayed FB; Droz JP; Tursz T; Brule CH
    Nouv Presse Med; 1980 Oct; 9(37):2705-6. PubMed ID: 6159573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity of anthracyclines. Apropos of 12 pediatric cases].
    Favrot MC; Pouyau G; Souillet G; Philip T; Bozzio A; Philippe N
    Pediatrie; 1981 Sep; 36(6):437-50. PubMed ID: 6947199
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy for benign and locally aggressive tumors: report of two cases.
    Hensley MF; Cangir A; van Eys J; Goepfert H
    Cancer Treat Rep; 1978 Jan; 62(1):167-8. PubMed ID: 203394
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography.
    Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G
    Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement.
    Lagrange JL; Thyss A; Caldani C; Héry M; Schneider M; Bensadoun JR
    Bull Cancer; 1988; 75(8):801-6. PubMed ID: 2460169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.
    Ahmann DL; Edmonson JH; Frytak S; Kvols LK; Bisel HF; Rubin J
    Cancer Treat Rep; 1978 Jan; 62(1):151-3. PubMed ID: 626995
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.